BEAT — HeartBeam, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1779372 ·
Last close
$0.33
Market Cap
$21.13M
52W High
$4.00
52W Low
$0.32
ADV30
1,416,583
Next earnings
2026-11-12
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -3,457,000 -3,010,000 7,872,000 6,065,000 1,358,000
Jun 2026 0 — -5,092,000 -5,039,000 10,637,000 8,722,000 2,460,000
Mar 2026 0 — -4,716,000 -4,700,000 3,929,000 2,039,000 3,294,000
Dec 2025 0 — -5,310,000 -5,302,000 5,843,000 4,380,000 3,240,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-13,018,000
Investing CF
$804,000
Financing CF
$17,681,000
CapEx
$-993,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.52
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-87,027,000
Inventory
$110,000
Receivables
—
ST Investments
$1,797,000
EBIT TTM
$-20,408,000
Pretax Income TTM
$-20,296,000
Interest Exp TTM
—
Analysts
2

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -21,139,000 -21,015,000 5,843,000 3,240,000 2,603,000 -13,988,000
Dec 2024 0 -19,887,000 -19,448,000 3,276,000 1,622,000 1,654,000 -14,471,000
Dec 2023 0 -15,314,000 -14,639,000 17,131,000 1,194,000 15,937,000 -12,093,000
Dec 2022 0 -13,031,000 -12,962,000 4,039,000 1,665,000 2,374,000 -9,948,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-20,296,000
OpCashFlow TTM
—
Assets (Latest)
$10,637,000
Forward EPS
$-0.53

Peers — same industry

TickerNameMarket CapLastDaily %
RDGL VIVOS INC $21.07M $0.04 —
NNOX Nano-X Imaging Ltd. $22.59M $0.29 —
ITOC iTonic Holdings Ltd $18.39M $1.96 —
FOFA FAMILY OFFICE OF AMERICA, INC. $24.66M $0.80 —
QTI QT IMAGING HOLDINGS, INC. $24.83M $1.69 —

News headlines (Yahoo Finance, 1h cache)

HeartBeam, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time
2026-11-03 13:31 · Yahoo
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
2026-10-28 12:31 · Yahoo
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
2026-10-26 12:31 · Yahoo
HeartBeam stock soars on FDA breakthrough designation
2026-10-05 15:05 · Yahoo
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
2026-10-05 14:20 · Yahoo
HeartBeam, Inc. Letter to Shareholders
2026-09-21 12:31 · Yahoo
HeartBeam, Inc. Q2 2026 Earnings Call Summary
2026-08-14 12:30 · Yahoo
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ...
2026-08-14 05:02 · Yahoo
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
2026-07-30 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.